![Jean-Simon Diallo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jean-Simon Diallo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Virica Biotech, Inc.
![]() Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Algemeen Directeur | 01-01-2018 | - |
Oprichter | 01-01-2018 | - |
Loopbaan van Jean-Simon Diallo
Statistieken
Internationaal
Canada | 2 |
Operationeel
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Virica Biotech, Inc.
![]() Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Health Technology |
- Beurs
- Insiders
- Jean-Simon Diallo
- Ervaring